Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)

NCT00160082 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Calliditas Therapeutics AB